
Akebia Therapeutics AKBA
€ 1.09
-2.29%
Geschäftsbericht 2025
hinzugefügt 26.02.2026
Akebia Therapeutics P/S 2011-2026 | AKBA
P/S Jährlich Akebia Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.42 | 1.71 | 1.32 | 0.481 | 1.69 | 1.63 | 2.66 | 3.22 | 3.67 | 241 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 241 | 0.481 | 25.9 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
11.7 | $ 2.13 | -12.55 % | $ 219 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
BioCardia
BCDA
|
18.6 | $ 1.37 | 6.2 % | $ 29 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
BioXcel Therapeutics
BTAI
|
2.37 | $ 1.64 | -1.8 % | $ 4.16 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
BeyondSpring
BYSI
|
69.6 | $ 1.44 | 6.3 % | $ 58.1 M | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 3.34 | 0.6 % | $ 3.9 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.7 | 2.49 % | $ 1.11 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Codexis
CDXS
|
4.91 | $ 1.05 | 3.47 % | $ 77.1 M | ||
|
Cerus Corporation
CERS
|
1.49 | $ 2.6 | 1.56 % | $ 480 M | ||
|
Certara
CERT
|
2.57 | $ 7.17 | 1.27 % | $ 1.15 B | ||
|
Cullinan Management
CGEM
|
35.1 | $ 15.91 | 2.65 % | $ 931 M | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 2.28 | 25.97 % | $ 204 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Coherus BioSciences
CHRS
|
0.813 | $ 1.66 | -0.9 % | $ 156 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 3.88 | - | $ 116 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Cocrystal Pharma
COCP
|
47.2 | $ 1.02 | -0.97 % | $ 10.4 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Collegium Pharmaceutical
COLL
|
6.81 | $ 42.0 | 0.79 % | $ 1.33 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
4.93 | $ 35.61 | -0.25 % | $ 3.7 B | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M |